To achieve the Aims of the Tennessee CFAR (TN-CFAR) will require an innovative, flexible, and engaged Administrative Core (AC). The significance and impact of the AC will be heightened by the tri-institutional structure of the TN-CFAR, making its work critical to the success of the program. The AC will add value to and enhance the significance of HIV/AIDS research at our partnered institutions by providing leadership and resources for collaborations that will impact the field. The work of the AC will be grounded in transparent communication, maximizing value-added through efficient use of financial and human resources, and commitment to serving the needs of HIV researchers across our diverse institutions. The AC will be the ?operating system? of the Tennessee CFAR, overseeing resources and creating a collaborative environment for TN-CFAR users through Cores and Scientific Working Groups (SWGs), respectively.
The Specific Aims of the AC are to: (1) Provide leadership, management, coordination, and supervision of TN-CFAR activities; (2) Enhance the productivity of all three partnered institutions in HIV/AIDS research by supporting and coordinating trans-disciplinary collaborations; and (3) Facilitate effective bi-directional communication about HIV/AIDS-related research resources and advances. The TN-CFAR will leverage Vanderbilt's immense strength in developing biomedical informatics tools to support research operations and the AC's strong expertise in creatively adapting these tools to optimize productivity. The AC will create a system of user- friendly REDCap databases (one for each Core and SWG) that support CFAR operations through real-time data collection for continuous quality improvement. This new and innovative resource will empower the AC and TN-CFAR to efficiently provide institutional leadership in HIV/AIDS, needed core services for TN-CFAR investigators, and mentoring of future leaders in HIV/AIDS research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI110527-05
Application #
9671854
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Stone Jr, Cosby A; Liu, Yiwei; Relling, Mary V et al. (2018) Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized. J Allergy Clin Immunol Pract :
Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459
Leger, Paul; Chirwa, Sanika; Nwogu, Jacinta N et al. (2018) Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation. Pharmacogenet Genomics 28:1-6
Trubiano, Jason A; Strautins, Kaija; Redwood, Alec J et al. (2018) The Combined Utility of Ex Vivo IFN-? Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions. J Allergy Clin Immunol Pract 6:1287-1296.e1
McGoy, Shanell L; Pettit, April C; Morrison, Melissa et al. (2018) Use of Social Network Strategy Among Young Black Men Who Have Sex With Men for HIV Testing, Linkage to Care, and Reengagement in Care, Tennessee, 2013-2016. Public Health Rep 133:43S-51S
Tan, Yi; Pickett, Brett E; Shrivastava, Susmita et al. (2018) Differing epidemiological dynamics of Chikungunya virus in the Americas during the 2014-2015 epidemic. PLoS Negl Trop Dis 12:e0006670
Trubiano, Jason A; Douglas, Abby P; Goh, Michelle et al. (2018) The safety of antibiotic skin testing in severe T-cell-mediated hypersensitivity of immunocompetent and immunocompromised hosts. J Allergy Clin Immunol Pract :
Stone Jr, Cosby A; Hemler, Jonathan A; Commins, Scott P et al. (2018) Reply. J Allergy Clin Immunol 141:1957-1958
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Cook, Kathryn M; Gillon, Jessica; Grisso, Alison G et al. (2018) Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin-Tazobactam or Cefepime: A Cohort Study. J Pediatric Infect Dis Soc :

Showing the most recent 10 out of 126 publications